HFM
GILD icon

Hartford Funds Management’s Gilead Sciences GILD Stock Holding History

Hartford Funds Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.53M Buy
18,175
+481
+3% +$67.4K 0.22% 21
2025
Q4 		$2.17M Buy
17,694
+4,846
+38% +$589K 0.18% 26
2025
Q3 		$1.43M Sell
12,848
-1,433
-10% -$163K 0.12% 27
2025
Q2 		$1.58M Buy
14,281
+7,034
+97% +$749K 0.14% 24
2025
Q1 		$812K Buy
7,247
+1,318
+22% +$136K 0.07% 66
2024
Q4 		$548K Buy
+5,929
New +$534K 0.05% 79

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Hartford Funds Management's GILD Position: Q1 2026 in Review

Hartford Funds Management increased its Gilead Sciences (GILD) stake by 2.7% in Q1 2026, buying an estimated $67.4K and bringing the position to 18,175 shares worth $2.53M. The position accounts for 0.22% of the portfolio, ranked #21.

Hartford Funds Management first reported a position in GILD in Q4 2024 and has held it in 6 quarters since. 2,310 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Hartford Funds Management held 18,175 shares of Gilead Sciences worth $2.53M as of Q1 2026.
  • Hartford Funds Management bought 481 Gilead Sciences shares in Q1 2026, an estimated $67.4K.
  • Gilead Sciences made up 0.22% of Hartford Funds Management's portfolio in Q1 2026, its #21 holding.
  • Hartford Funds Management first reported a position in Gilead Sciences in Q4 2024 and has held it in 6 quarters since.
  • 2,310 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Hartford Funds Management's 13F filing for Q1 2026, filed 4 May 2026.